Shares of Glenmark Pharmaceuticals surged 5 per cent after the company reported better-than-expected earnings.
Glenmark Pharma reported a consolidated net profit of Rs. 216 crore in the October-December quarter, compared with the mean consensus forecasts of Rs. 181 crore, compiled by Thomson Reuters StarMine.
The stock ended at Rs. 535.90 on the NSE, up Rs. 25.50 or 5 per cent against a 2.1 per cent drop in the broader Nifty benchmark.
Glenmark Pharma reported a consolidated net profit of Rs. 216 crore in the October-December quarter, compared with the mean consensus forecasts of Rs. 181 crore, compiled by Thomson Reuters StarMine.
The stock ended at Rs. 535.90 on the NSE, up Rs. 25.50 or 5 per cent against a 2.1 per cent drop in the broader Nifty benchmark.
0 comments:
Post a Comment